-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga·04/01/2025 21:05:46
Listen to the news

Gainers

  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 26.7% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $6.7 million.
  • bioAffinity Technologies (NASDAQ:BIAF) stock rose 11.92% to $1.22. The market value of their outstanding shares is at $19.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Biodesix (NASDAQ:BDSX) stock moved upwards by 10.24% to $0.67. The company's market cap stands at $97.0 million.
  • DIH Holding US (NASDAQ:DHAI) shares moved upwards by 8.88% to $0.24. The company's market cap stands at $11.5 million.
  • Know Labs (AMEX:KNW) shares moved upwards by 8.58% to $0.76. The market value of their outstanding shares is at $2.1 million.
  • Co-Diagnostics (NASDAQ:CODX) shares increased by 6.96% to $0.34. The market value of their outstanding shares is at $10.9 million. As per the press release, Q4 earnings came out 3 days ago.

Losers

  • Venus Concept (NASDAQ:VERO) shares fell 17.9% to $2.15 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 million. As per the press release, Q4 earnings came out yesterday.
  • TNF Pharmaceuticals (NASDAQ:TNFA) shares decreased by 17.63% to $0.36. The company's market cap stands at $1.0 million.
  • HCW Biologics (NASDAQ:HCWB) shares fell 14.57% to $0.24. The company's market cap stands at $10.6 million. The company's, Q4 earnings came out 2 days ago.
  • Regencell Bioscience (NASDAQ:RGC) stock decreased by 10.32% to $26.0. The market value of their outstanding shares is at $338.3 million.
  • Ocean Biomedical (NASDAQ:OCEA) stock fell 9.29% to $0.05. The market value of their outstanding shares is at $7.0 million.
  • GlucoTrack (NASDAQ:GCTK) stock fell 7.56% to $0.21. The company's market cap stands at $2.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.